Penumbra, Inc. Schedules Third Quarter 2018 Earnings Release and Conference Call for November 5, 2018

ALAMEDA, Calif., Oct. 15, 2018 /PRNewswire/ — Penumbra, Inc. (NYSE: PEN) today announced that it will host a conference call to discuss financial results for the third quarter 2018 after market close on Monday, November 5, 2018 at 5:00 PM Eastern Time. A press release with third quarter 2018 financial results will be issued after market […]

Abbott Names Robert B. Ford President, Chief Operating Officer

ABBOTT PARK, Ill., Oct. 15, 2018 /PRNewswire/ — Abbott (NYSE: ABT) announced today that Robert B. Ford has been named president and chief operating officer, effective immediately. Mr. Ford, a 22-year Abbott veteran, was most recently executive vice president of Medical Devices, Abbott’s largest business. In addition to his current responsibilities for Medical Devices, Mr. Ford, 45, […]

Acasti Pharma Announces Closing of $19.1 Million Underwritten Public Offering of Common Shares

MONTRÉAL, Oct. 11, 2018 (GLOBE NEWSWIRE) — Acasti Pharma Inc. (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of its prescription drug candidate CaPre® (omega-3 phospholipid) for the treatment of severe hypertriglyceridemia, announced today the closing of its previously announced underwritten public offering […]

Orchestra BioMed™ Strengthens Operations, R&D and Pharmaceutical Development Expertise with Key Leadership Team Additions

NEW HOPE, Pa., Oct. 10, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing high impact, high value, evidence-based therapeutic solutions for medical procedures that address major medical conditions, announced today that it has appointed three key members to its management team. Joining the […]

iRhythm Technologies to Report Third Quarter Financial Results on October 30, 2018

SAN FRANCISCO, Oct. 09, 2018 (GLOBE NEWSWIRE) — iRhythm Technologies, Inc. (NASDAQ: IRTC), a leading digital healthcare solutions company focused on the advancement of cardiac care, today announced that it will release financial results for the third quarter 2018 after the close of trading on Tuesday, October 30, 2018.  The company’s […]

Cardialen Closes $17 Million Series B Financing for Heart Rhythm Therapy

MINNEAPOLIS–(BUSINESS WIRE)–Cardialen, Inc., a medical device company developing a low-energy implantable defibrillation therapy designed to more gently restore normal heart rhythm, announced today the closing of a $17 million Series B investment led by RiverVest Venture Partners, along with Qiming Venture Partners, HBM Healthcare Investments and Cultivation Capital. The financing will […]

Cagent Vascular Appoints Medical Device Industry Veteran Brian Walsh as Chairman of the Board

WAYNE, Pa.–(BUSINESS WIRE)–Cagent Vascular®, a developer of next generation angioplasty balloons using proprietary serration technology, announces Brian Walsh to serve as Chairman of the Board. Brian Walsh has held several executive level positions in cardiovascular and ophthalmology specialties within the medical device industry. Mr. Walsh currently serves as the President […]

Orchestra BioMed™ Adds Three Industry Leaders to Strategic Advisory Board

NEW HOPE, Pa., Oct. 09, 2018 (GLOBE NEWSWIRE) — Orchestra BioMed, Inc. (“Orchestra BioMed” or the “Company”), a biomedical innovation company developing transformational therapeutic devices targeting major medical conditions, announced today the appointment of three new members to its Strategic Advisory Board (“SAB”). Joining the Company’s SAB is Gary J. Pruden, former […]